Volume 2, Supplement 1, March 2001
Angiotensin II receptor blockade: effects beyond blood pressure controlSUPPLEMENTPromise of prevention and reversal of target organ involvement in hypertension Edward D Frohlich POPULAR TOPICSUPPLEMENTGene targeting studies of angiotensin II type 1 (AT1) receptors Thomas M Coffman, Laurent P Audoly, Michael I Oliverio POPULAR TOPICSUPPLEMENTStructural requirements for signalling and regulation of AT1-receptors László Hunyady, Zsuzsanna Gáborik, Georges Vauquelin, Kevin J Catt POPULAR TOPICSUPPLEMENTDistinctions between non-peptide angiotensin II AT1-receptor antagonists Georges Vauquelin, Frederik LP Fierens, Ilse Verheijen, Patrick ML Vanderheyden SUPPLEMENTRole of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan Georges Vauquelin, Frederik LP Fierens, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, Patrick ML Vanderheyden SUPPLEMENTCharacterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries Hoa Ytterberg, Lars Edvinsson SUPPLEMENTEvidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries Hoa Ytterberg, Lars Edvinsson SUPPLEMENTAnalysis of responses to angiotensin II in the mouse Trinity J Bivalacqua, Hunter C Champion, Albert L Hyman, Dennis B McNamara, Philip J Kadowitz SUPPLEMENTDoes protein binding modulate the effect of angiotensin II receptor antagonists? Marc P Maillard, Catherine Centeno, Åsa Frostell-Karlsson, Hans R Brunner, Michel Burnier POPULAR TOPICSUPPLEMENTInteraction among angiotensin II, nitric oxide and oxidative stress Ming-Sheng Zhou, Ahmed Adam, Leopoldo Raij SUPPLEMENTImprovement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade? Lodewijk J Wagenaar, Hendrik Buikema, Yigal M Pinto, Wiek H van Gilst POPULAR TOPICSUPPLEMENTFacilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells Jawahar L Mehta, Dayuan Li SUPPLEMENTPrevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil Vasilios Papademetriou, Philippe Mammillot, Robert Redman, Aldo Notargiacomo, Puneet Narayan, Raj Lakshman SUPPLEMENTEffects of low-dose candesartan on the rate of re-endothelialisation following vascular wound healing Prakash Koshy, Amanda Self, Philip J Kadowitz, Vivian A Fonseca, Dennis B McNamara SUPPLEMENTCandesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects Daniel Casellas, Abderraouf Herizi, Annie Artuso, Albert Mimran, Bernard Jover SUPPLEMENTPersistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats Karin Skov, Susie Mogensen, Michael J Mulvany SUPPLEMENTAT1-receptors in the central nervous system Andrew M Allen, Michelle E Giles, JooHyung Lee, Brian J Oldfield, Frederick AO Mendelsohn, Michael J McKinley SUPPLEMENTThe role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia Juan M Saavedra, Takeshi Ito, Yasuaki Nishimura POPULAR TOPICSUPPLEMENTRole of angiotensin in central regulation of sympathetic activity: effect of dietary sodium chloride Gerald F DiBona POPULAR TOPICSUPPLEMENTThe renin-angiotensin system in obesity hypertension Arya M Sharma, Stefan Engeli SUPPLEMENTBlockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge Andrew M Allen SUPPLEMENTDevelopment of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms Donna H Wang, Yan Huang POPULAR TOPICSUPPLEMENTCandesartan decreases the sympatho-adrenal and hormonal response to isolation stress Ines Armando, Andrea Carranza, Yasuaki Nishimura, Marta Barontini, Takeshi Ito, Juan M Saavedra SUPPLEMENTAT1-receptor blockade in experimental myocardial ischaemia/reperfusion Rainer Schulz, Gerd Heusch SUPPLEMENTReversal of cardiovascular remodelling with candesartan Lindsay Brown, Andrew Fenning, Annie Shek, Darryl Burstow POPULAR TOPICSUPPLEMENTRegression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction Emad Abro, Cory D Griffiths, Trefor O Morgan, Lea MD Delbridge POPULAR TOPICSUPPLEMENTCandesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy Djamel Lebeche, Zhao Bin Kang, Roger Hajjar POPULAR TOPICSUPPLEMENTCardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor Bodh I Jugdutt, Yi Xu, Mohammed Balghith, Vijayan Menon SUPPLEMENTLessons on renal function from transgenic mice lacking different angiotensin II receptors William J Arendshorst SUPPLEMENTIntrarenal angiotensin II levels in normal and hypertensive states L Gabriel Navar, Kenneth D Mitchell, Lisa M Harrison-Bernard, Hiroyuki Kobori, Akira Nishiyama POPULAR TOPICSUPPLEMENTThe renin-angiotensin-aldosterone system, blockade and diabetic nephropathy Norman K Hollenberg SUPPLEMENTThe role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy Matthew R Weir, Chiming Wei SUPPLEMENTRelative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model Karen A Griffin, Maria M Picken, George Bakris, Anil K Bidani POPULAR TOPICSUPPLEMENTThe effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion Marc S Weinberg, Adam J Weinberg, Raymond Cord, Dion H Zappe SUPPLEMENTAngiotensin II blockade causes acute renal failure in eNOS-deficient mice Jürgen Schnermann, Yuning G Huang, Josie P Briggs POPULAR TOPICSUPPLEMENTComparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction William F van Rodijnen, Ton A van Lambalgen, Marco E van Teijlingen, Geert-Jan Tangelder, Piet M ter Wee SUPPLEMENTImprovements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats Jean-Jacques Boffa, Ying Lu, Jean-Claude Dussaule, Christos Chatziantoniou SUPPLEMENTUse of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial Matthew R Weir, Rebecca Y Wang POPULAR TOPICSUPPLEMENTEffect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease Trefor Morgan
|